Benchtalk West's Panel Discussion: Making the Tough Decisions - Planning, Optimizing, and Measuring Life Science R&D

[iframe https://www.youtube.com/embed/AlmjxRcVEXI]

Emerging technologies are revolutionizing life as we know it - from the medicines we take to the clothes we wear. But to perfect the innovations of tomorrow, R&D organizations need to properly forecast their highly complex processes, so that a spark of genius successfully develops from an idea into a product. At Benchtalk West 2019, a panel of life science leaders discussed the ins and outs of planning for success and scaling iterative R&D processes. Listen in to join the conversation on preparing to scale before you have data, improving iteration after iteration, and inspiring team-wide collaboration.

This panel discussion features the following speakers:

  • Kristy Hawkins, Co-Founder and CSO at Antheia

  • Hari Jayaram, VP of Technology at Spotlight Therapeutics

  • Jackie Papkoff, CSO of Microbiome at Assembly Biosciences

  • Chris Bond, Biopharma Executive

You can find information on upcoming Benchling events here, or check out the following posts for more articles and videos of Benchtalk West.

Highlights from Benchtalk West

Five Key Takeaways from Benchtalk West

Adicet Bio: Building the Next Generation of Cellular Therapies

Bolt Threads: Leveraging Data to Engineer Revolutionary, Nature-Inspired Materials